BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 26339893)

  • 1. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Andrade FM; Oliveira AD; Lopes AJ
    Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
    Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
    Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
    Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
    Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
    Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on pulmonary complications of systemic sclerosis in eastern India.
    Ghosh A; Banerjee A; Biswas AK
    Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F; Mugii N; Oohata S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
    Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
    Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
    Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
    Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease.
    Chetta A; Aiello M; Foresi A; Marangio E; D'Ippolito R; Castagnaro A; Olivieri D
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Jun; 18(2):170-5. PubMed ID: 11436537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V; Franssen FM; Peeters JP; Ubachs TJ; Bukari H; Groenen M; Burtin C; Vogiatzis I; Wouters EF; Spruit MA
    Respir Physiol Neurobiol; 2014 Jan; 190():40-6. PubMed ID: 24121092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease.
    Briand J; Behal H; Chenivesse C; Wémeau-Stervinou L; Wallaert B
    Ther Adv Respir Dis; 2018; 12():1753466618793028. PubMed ID: 30091679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
    Wu W; Jordan S; Becker MO; Dobrota R; Maurer B; Fretheim H; Ye S; Siegert E; Allanore Y; Hoffmann-Vold AM; Distler O
    Ann Rheum Dis; 2018 Sep; 77(9):1326-1332. PubMed ID: 29875097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung involvement in systemic sclerosis].
    Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
    Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.